Furthermore, VIRMA knockdown in CML cell lines recapitulates the effect of targeting the methyltransferase complex, leading to decreased proliferation and viability [26]. The gene discussed is VIRMA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.